Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek

Xiaoling Li

Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek

Xiaoling Li is a Professor of Pharmaceutics and Associate Dean of Graduate Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific. He is Co-founder and Chief Scientific Officer, Triastek, Inc., China. Xiaoling Li will speak about Application of 3D Printing Technology in Dosage Form Design and Drug Delivery during the 3D Medical Printing Conference, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

What drives you?

Innovation, science and technology Continue reading “Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek”

IoT in a patient follow-up tool to have greatest potential – Stijn Bukenbergs, Thomas More

Stijn Bukenbergs

IoT in a patient follow-up tool to have greatest potential – Stijn Bukenbergs, Thomas More

Stijn Bukenbergs is Lecturer/researcher at Thomas More University College in Belgium. He will speak about Active smart wearable orthotics for therapy (ARTHE) during the 3D Medical Conference 2018, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands. 

What drives you?

Bringing new ideas into practice Continue reading “IoT in a patient follow-up tool to have greatest potential – Stijn Bukenbergs, Thomas More”

Rik Jacobs, 3D Systems, will speak at the 3D Medical Conference

Rik Jacobs

Rik Jacobs, 3D Systems, will speak at the 3D Medical Conference,  which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

About Rik Jacobs
Rik Jacobs is a founder and the former CEO of NextDent B.V. The company was founded in 2012 in the Netherlands as an independent subsidiary of Vertex Global Holding to complement the dental materials portfolio of its affiliate Vertex-Dental B.V., which has a 77-year track record in developing and producing traditional denture materials and products. Within four years, NextDent became the leading developer and manufacturer of biocompatible dental 3D printing materials. In January 2017, Vertex Global Holding merged with 3D Systems, a company that provides comprehensive Additive Manufacturing products and services, including 3D printers specifically designed for dental applications, print materials, on-demand parts services and digital design tools. Upon this merger, Rik became the General Manager of the Dental business. He holds a degree in International Marketing Management from NHL University of Applied Science. Continue reading “Rik Jacobs, 3D Systems, will speak at the 3D Medical Conference”

3D Medical Conference welcomes 3DHeals as Media Partner

3DHeals

3D Medical Conference welcomes 3DHeals as Media Partner. The event will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

About 3DHeals
3DHEALS was founded to create an ecosystem of healthcare 3D printing and bioprinting through events, educational programs, online content, and consultancy.

It aims to facilitate global multidisciplinary collaborative innovations in health care 3D printing and helps with quality control, standardization, and scaling of health care 3D printing. Continue reading “3D Medical Conference welcomes 3DHeals as Media Partner”

From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists

Tobias Gantner

From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists, at the 3D Medical Conference 2018, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

Digital Production of Medicines is already quite advanced. The bigger hurdle is to take the regulatory and reimbursement hurdle. In order to prove the added value that this novel technology might bring to patients and caregivers alike, certain requirements will have to be met. This accounts for the overall goals of digital production of medicines as well as to infrastructural necessities that have to be secured such as machinery both on the producer’s and dispenser’s side as well as on the consumer’s part. This talk will discuss how going to market strategies could look like in the light of technological advancements and price deteriorations. We will be looking at changing business models and challenging new approaches such as value-based healthcare in the age of 3D printing of medications. Continue reading “From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists”

3D Medical Conference welcomes ECHAlliance as Media Partner

ECHAlliance

3D Medical Conference welcomes ECHAlliance as Media Partner

About ECHAlliance

The ECHAlliance is a Community Interest Company (CIC) registered in Belfast – Northern Ireland (UK). We are a not-for-profit organisation.

Facilitating international multi-stakeholder connections around ecosystems, driving sustainable change and disruption in the delivery of health and social care. Continue reading “3D Medical Conference welcomes ECHAlliance as Media Partner”

Application of 3D printing technology in dosage form design & drug delivery – Presented by Senping Cheng, Triastek

Senping Cheng

Application of 3D printing technology in dosage form design and drug delivery – Presented by Senping Cheng, Triastek at the 3D Medical Conference 5th edition, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

Triastek has developed the fused deposition modeling (FDM) 3D printer with multiple printer heads for creating the complex pharmaceutcial dosage forms. The unique architecture of tablet is created with one or more compartment(s) or chamber(s) within a tablet. These compartments can hold drug(s) in a specailly designed formulation to modulate the release of active ingredient(s) at a predetermined time and rate in a given mode. Onset time, mode of drug release, and release rate could affect the efficacy and outcome of drug therapy. Therefore, rational use of these characteristics of drug release can achieve desired or synergistic pharmacological effect in clinical application of one or more drug(s). Mixing and/or matching these characteristics of drug release to meet the clinical needs for various therapeutic regimens can be achieved by creating one single tablet using 3D printing technology. Continue reading “Application of 3D printing technology in dosage form design & drug delivery – Presented by Senping Cheng, Triastek”